During the past decade, Hospital Universitario de Mostoles conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 6 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 3 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario de Mostoles" #1 sponsor was "Spanish Breast Cancer Research Group" with 4 trials, followed by "Grupo Español de Rehabilitación Multimodal" with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "Spanish Lung Cancer Group" with 3 trials sponsored and "Abbott" with 3 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario de Mostoles" #1 collaborator was "Pfizer" with 2 trials as a collaborator, "AECC_Asociación Española contra el Cáncer" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Effice Servicios Para la Investigacion S.L." with 1 trials as a collaborator and "Fondo de Investigacion Sanitaria" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario de Mostoles" are "HIV Infections" (3 trials), "Lung Cancer" (3 trials), "Perioperative Care" (3 trials), "Postoperative Complications" (3 trials) and "Postoperative Pain" (2 trials). Many other conditions were trialed in "Hospital Universitario de Mostoles" in a lesser frequency.

Most popular intervention types in "Hospital Universitario de Mostoles" are "Drug" (26 trials), "Other" (3 trials), "Diagnostic Test" (2 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Lopinavir/Ritonavir" (2 trials), "ATRA" (1 trials), "Abacavir+lamivudine" (1 trials) and "Abemaciclib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario de Mostoles" are 40 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Universitario de Mostoles". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Hospital Universitario de Mostoles, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario de Mostoles, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 1 trials that are defined as “Not Applicable".

Hospital Universitario de Mostoles has several departments that took part in Clinical trials: "Hosital Universitario de Mostoles;Servicio de Hematologia" - 2 trials